Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

BACKGROUND: There is an increasing interest in cognitive and functional outcomes in the respective stages of Alzheimer’s disease (AD) and in novel therapies particularly for the milder phases of AD. Our aim was to describe and compare various aspects of disease progression in patients with mild vers...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Minthon, Lennart, Wallin, Åsa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756534/
https://www.ncbi.nlm.nih.gov/pubmed/26883213
http://dx.doi.org/10.1186/s13195-016-0174-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756534/
https://www.ncbi.nlm.nih.gov/pubmed/26883213
http://dx.doi.org/10.1186/s13195-016-0174-1

Ejemplares similares